Thomas Catinazzo Relay Therapeutics, Inc. (RLAY) insider trading activity

Thomas Catinazzo is Chief Financial Officer of Relay Therapeutics, Inc.. Currently has a direct ownership of 319,650 shares of RLAY, which is worth approximately $1.99 Million. The most recent transaction as insider was on Jul 29, 2024, when has been sold 10,780 shares (Common Stock) at a price of $8.68 per share, resulting in proceeds of $93,570. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 320K

5.93% 3M change

118.73% 12M change

Total Value Held $1.99 Million

Thomas Catinazzo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 29 2024	SELL Open market or private sale	$93,570 $8.68 p/Share	10,780 Reduced 3.26%	319,650 Common Stock
Jun 27 2024	SELL Open market or private sale	$58,581 $6.25 p/Share	9,373 Reduced 2.76%	330,430 Common Stock
Apr 29 2024	SELL Open market or private sale	$10,814 $6.38 p/Share	1,695 Reduced 0.5%	339,803 Common Stock
Mar 27 2024	SELL Open market or private sale	$2,679 $7.7 p/Share	348 Reduced 0.1%	341,498 Common Stock
Jan 29 2024	SELL Open market or private sale	$19,328 $9.64 p/Share	2,005 Reduced 0.58%	341,846 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	-	200,000 Added 36.77%	343,851 Common Stock
Dec 27 2023	SELL Open market or private sale	$3,383 $11.51 p/Share	294 Reduced 0.2%	143,851 Common Stock
Oct 30 2023	SELL Open market or private sale	$10,232 $6.03 p/Share	1,697 Reduced 1.16%	144,145 Common Stock
Sep 27 2023	SELL Open market or private sale	$2,463 $8.38 p/Share	294 Reduced 0.2%	145,842 Common Stock
Jul 28 2023	SELL Open market or private sale	$19,977 $11.8 p/Share	1,693 Reduced 1.15%	146,136 Common Stock
Jun 27 2023	SELL Open market or private sale	$3,563 $12.12 p/Share	294 Reduced 0.2%	147,829 Common Stock
Apr 28 2023	SELL Open market or private sale	$9,631 $11.16 p/Share	863 Reduced 0.57%	149,272 Common Stock
Mar 27 2023	SELL Open market or private sale	$5,329 $15.36 p/Share	347 Reduced 0.23%	150,135 Common Stock
Jan 30 2023	SELL Open market or private sale	$18,627 $21.56 p/Share	864 Reduced 0.57%	150,482 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	-	101,115 Added 40.05%	151,346 Common Stock
Dec 27 2022	SELL Open market or private sale	$6,448 $14.49 p/Share	445 Reduced 0.88%	50,231 Common Stock
Oct 28 2022	SELL Open market or private sale	$23,672 $21.54 p/Share	1,099 Reduced 2.12%	50,676 Common Stock
Sep 27 2022	SELL Open market or private sale	$10,069 $22.73 p/Share	443 Reduced 0.85%	51,775 Common Stock
Sep 08 2022	SELL Open market or private sale	$787,710 $30.0 p/Share	26,257 Reduced 33.46%	52,218 Common Stock
Sep 08 2022	BUY Exercise of conversion of derivative security	$108,179 $4.12 p/Share	26,257 Added 25.07%	78,475 Common Stock
Jul 28 2022	SELL Open market or private sale	$15,605 $21.26 p/Share	734 Reduced 1.39%	52,218 Common Stock
Jun 27 2022	SELL Open market or private sale	$6,093 $20.31 p/Share	300 Reduced 0.56%	52,952 Common Stock
Apr 28 2022	SELL Open market or private sale	$18,538 $25.57 p/Share	725 Reduced 1.34%	53,252 Common Stock
Mar 29 2022	SELL Open market or private sale	$8,423 $29.87 p/Share	282 Reduced 0.52%	53,977 Common Stock
Mar 24 2022	SELL Open market or private sale	$398,580 $30.0 p/Share	13,286 Reduced 19.67%	54,259 Common Stock

Thomas Catinazzo

Chief Financial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLAY shares.

Notify only if

Value

Insider Trading

Get notified when an Relay Therapeutics, Inc. insider buys or sells RLAY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Relay Therapeutics, Inc.

Track Activities on RLAY

Account